SII, Oxford Univ tie up for Nipah virus vaccine manufacture with $7.3 million funding

SII will collaborate with CEPI and the University of Oxford to produce the ChAdOx1 NipahB vaccine for Phase II clinical ...
Reuters

AstraZeneca says its Oxford vaccine deal allows it to add up to 20% of manufacturing costs

Oct 23 (Reuters) - AstraZeneca Plc (AZN.L), opens new tab said on Friday its coronavirus vaccine deal with Oxford University will allow it to add up to 20% of manufacturing costs to cover additional ...
Reuters

Britain and other nations press on with AstraZeneca vaccine amid trial questions

LONDON/MANILA, Nov 27 (Reuters) - Britain asked its regulator on Friday to assess AstraZeneca's COVID-19 vaccine for a possible rollout, while the Philippines and Thailand secured millions of doses, ...